Norepinephrine Zentiva (Norepinephrine)

Norepinephrine works by directly stimulating α1‑adrenergic receptors on blood vessels, causing strong vasoconstriction, and β1‑adrenergic receptors in the heart, increasing contractility and heart rate. This dual action raises systemic vascular resistance and cardiac output, thereby elevating arterial blood pressure in patients with life‑threatening hypotension.

The dosing regimen for Norepinephrine Zentiva is individualized by the prescribing clinician based on the patient’s hemodynamic status, response to therapy, and underlying condition. Typically, it is administered as a continuous intravenous infusion that is titrated to achieve target blood pressure, but exact rates are determined at the bedside.

The pregnancy category for norepinephrine is listed as unknown, and there are limited data on its use in pregnant or lactating women. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including cold‑chain logistics if needed) and assists with import documentation.

Norepinephrine is often preferred over agents like dopamine or phenylephrine because it provides balanced α‑ and β‑adrenergic stimulation, leading to effective blood pressure support with less tachycardia than dopamine. Phenylephrine offers pure α‑agonism, which may cause reflex bradycardia. Choice of agent depends on the clinical scenario and physician judgment.

Norepinephrine Zentiva should be stored refrigerated at 2‑8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the solution. If the product reaches room temperature for a short period, it may be used, but it should be returned to refrigeration promptly.

The medication is supplied as an injectable solution for intravenous use. It is typically administered via a central venous catheter or a dedicated peripheral line using a calibrated infusion pump. Continuous monitoring of blood pressure and heart rate is essential while the infusion is running.

Serious risks include severe hypertension, myocardial ischemia, life‑threatening arrhythmias, and tissue necrosis if the drug extravasates from the vein. Clinicians must monitor cardiovascular parameters closely and ensure proper intravenous access to minimize these potentially fatal complications.

Norepinephrine is contraindicated in patients with known hypersensitivity to the drug, uncorrected tachyarrhythmias, pheochromocytoma, or severe peripheral vascular disease where vasoconstriction could worsen tissue perfusion. Use in these populations should be avoided or undertaken only with specialist supervision.